Chemotherapy with preoperative radiotherapy in rectal cancer.
about
Combination chemotherapy versus single-agent chemotherapy during preoperative chemoradiation for resectable rectal cancerPreoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancerPostoperative adjuvant chemotherapy in rectal cancer operated for curePre-operative chemoradiation for non-metastatic locally advanced rectal cancerCombination chemotherapy versus single agent chemotherapy during preoperative chemoradiation for resectable rectal cancerPreoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancerPre-operative radiotherapy and curative surgery for the management of localized rectal carcinomaPreoperative, intraoperative and postoperative risk factors for anastomotic leakage after laparoscopic low anterior resection with double stapling technique anastomosisA Review of Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal CancerChallenges of Using High-Dose Fractionation Radiotherapy in Combination TherapyLaparoscopic complete mesocolic excision with central vascular ligation in right colon cancer: A comprehensive reviewAdjuvant chemotherapy for rectal cancer: Is it needed?Neoadjuvant Rectal (NAR) Score: a New Surrogate Endpoint in Rectal Cancer Clinical TrialsNeoadjuvant chemoradiation therapy and pathological complete response in rectal cancerInnovations and developments in surgical coloproctologyTherapeutic strategies for synchronous and multiple liver metastases from colorectal cancerNeoadjuvant chemotherapy without radiotherapy for locally advanced rectal cancerRectal cancer: An evidence-based update for primary care providersLow thrombospondin 2 expression is predictive of low tumor regression after neoadjuvant chemoradiotherapy in rectal cancer.The Role of Lymphocytes in Radiotherapy-Induced Adverse Late Effects in the LungCurrent debate in the oncologic management of rectal cancer.Cardiopulmonary exercise testing, prehabilitation, and Enhanced Recovery After Surgery (ERAS)Unresolved issues and controversies surrounding the management of colorectal cancer liver metastasisIntraoperative radiotherapy in colorectal cancer: systematic review and meta-analysis of techniques, long-term outcomes, and complicationsA comparison of dosimetric parameters between tomotherapy and three-dimensional conformal radiotherapy in rectal cancerGene polymorphisms predict toxicity to neoadjuvant therapy in patients with rectal cancerNeoadjuvant treatment for rectal cancer-A value-based proposition.Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and'Liver-first' approach for metastatic colorectal cancer.Postoperative chemotherapy use after neoadjuvant chemoradiotherapy for rectal cancer: Analysis of Surveillance, Epidemiology, and End Results-Medicare data, 1998-2007Laparoscopic versus open low anterior resection for rectal cancer: results from the national cancer data base.Is Chemotherapy or Radiation Therapy in Addition to Surgery Beneficial for Locally Advanced Rectal Cancer in the Elderly? A National Cancer Data Base (NCDB) Study.Value of transrectal ultrasonography for tumor node metastasis restaging in patients with locally advanced rectal cancer after neoadjuvant chemoradiotherapyPreoperative short-course radiotherapy versus combined radiochemotherapy in locally advanced rectal cancer: a multi-centre prospectively randomised study of the Berlin Cancer Society.Evaluation of capecitabine and oxaliplatin administered prior to and then concomitant to radiotherapy in high risk locally advanced rectal cancer.Neoadjuvant chronomodulated capecitabine with radiotherapy in rectal cancer: a phase II brunch regimen study.Oxaliplatin/fluorouracil-based adjuvant chemotherapy for locally advanced rectal cancer after neoadjuvant chemoradiotherapy and surgery: a systematic review and meta-analysis of randomized controlled trials.Efficacy and safety of neoadjuvant chemotherapy with oxaliplatin, 5-fluorouracil, and levofolinate for T3 or T4 stage II/III rectal cancer: the FACT trial.Pre-operative hyperfractionated concurrent radiochemotherapy for locally advanced rectal cancers: a phase II clinical study.Management of locally advanced primary and recurrent rectal cancer.
P2860
Q24186443-4FCC8592-44CE-465E-9A60-2EEDD9B8C320Q24200568-81AA6603-BB34-4977-90CA-2F2865E27726Q24201072-64F5F1FD-5A3B-49B0-9CE4-01505784E18EQ24202425-D5C91179-AB4C-494C-81F6-E00D12274D33Q24235103-B3FC1D5D-09C3-4F4D-AD52-7846CFA8AB0AQ24241258-BF8CB346-D36A-4986-9F68-C8377A3CBEC8Q24245030-2B850D74-2F8A-4D90-BB69-49B3965FFA0AQ26739044-C6F69F20-4278-4340-BAF4-2ADC0033816DQ26739607-291EAB4F-287E-4B4D-A575-B10943D358E9Q26742107-6D61E094-C3EF-44D7-A73A-B6989C24999DQ26765225-9D65A1E3-138C-403F-8F4D-ABB68B6AAF76Q26775099-87749B00-C0E8-497A-9071-640C189523DDQ26796253-DBD05779-914A-4F33-86CD-ED67D566FAA4Q26796352-35A48F55-D6EB-4F7E-995A-767B575405FAQ26822454-8CFFAC56-9423-41EB-8837-60ADB25A5390Q26829522-9CD8EC1A-E50B-4B27-A0B9-D8E48FA71487Q27003878-CFCE68E4-46A7-4DD3-A67B-4052DBB923D8Q27013068-0F2C21A3-0700-4B8F-A58D-182DC82FB7C0Q27853327-8E00C656-4137-4AA7-B6DC-94E470DFDA98Q28070412-A7BB33BA-3B7C-4D43-8084-ED4009751B77Q28072948-5962C998-4F17-4AEC-AAA8-92C846A883C6Q28083172-3A63CDAF-50F2-4815-9807-5A49D965790EQ28085651-81640701-E7D9-47A5-BD2F-FC810615764EQ28282290-08D1A014-3FC5-4D4D-BD93-6F7991EBD9E0Q28294759-FBDADDCA-E19E-458C-AA51-1960EFE8F820Q28392548-0B35FBDD-E164-47FC-A3F3-0DFC55E678C4Q30251516-67ED20AC-C742-4B77-95D7-C452171F5425Q30370343-1C8D8E39-CA8F-4F02-BCAE-8F6F9D0CE468Q30373308-6F3A952E-0DF3-40D7-AE31-748B351EA63BQ30744596-8A29C302-971C-4134-BB7C-42A0238CCD18Q30840652-3F048439-69BF-475E-9E99-93E13E5CF9F6Q31023316-E0E8A5C2-68D8-4C86-8D4F-F5621DAAAF2EQ31159470-6F7E702E-6CB3-404F-B33B-9FD23415B042Q33406632-9CDC4DE7-989C-42D6-B52E-0F14D132C932Q33411783-4C5F5796-9D51-4025-8E10-2AF34B1336C4Q33416945-238C6FE0-229E-4C64-82A5-98BA59715D0DQ33432180-76FA0119-E866-4CFC-9B3A-9F71C0C73B26Q33438899-AD3B8DD3-6B1D-42B7-A497-435347193523Q33441568-82E60B44-FF26-45EE-AEE8-8BC75CFA49C0Q33518491-3DCB3F9B-3061-422C-80AF-B79D320A2E0A
P2860
Chemotherapy with preoperative radiotherapy in rectal cancer.
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Chemotherapy with preoperative radiotherapy in rectal cancer.
@ast
Chemotherapy with preoperative radiotherapy in rectal cancer.
@en
Chemotherapy with preoperative radiotherapy in rectal cancer.
@nl
type
label
Chemotherapy with preoperative radiotherapy in rectal cancer.
@ast
Chemotherapy with preoperative radiotherapy in rectal cancer.
@en
Chemotherapy with preoperative radiotherapy in rectal cancer.
@nl
prefLabel
Chemotherapy with preoperative radiotherapy in rectal cancer.
@ast
Chemotherapy with preoperative radiotherapy in rectal cancer.
@en
Chemotherapy with preoperative radiotherapy in rectal cancer.
@nl
P2093
P356
P1476
Chemotherapy with preoperative radiotherapy in rectal cancer.
@en
P2093
Alain Daban
Alexander Beny
EORTC Radiotherapy Group Trial 22921
Etienne Bardet
Gilles Calais
Jean-Claude Ollier
Jean-François Bosset
Laurence Collette
Laurent Mineur
Ljiljana Radosevic-Jelic
P304
P356
10.1056/NEJMOA060829
P407
P577
2006-09-01T00:00:00Z